0001209191-23-025625.txt : 20230425
0001209191-23-025625.hdr.sgml : 20230425
20230425210308
ACCESSION NUMBER: 0001209191-23-025625
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230425
DATE AS OF CHANGE: 20230425
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARDINER SANDRA A.
CENTRAL INDEX KEY: 0001218574
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 23846538
MAIL ADDRESS:
STREET 1: CUTERA, INC.
STREET 2: 3240 BAYSHORE BOULEVARD
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER NAME:
FORMER CONFORMED NAME: GARDINER SANDRA
DATE OF NAME CHANGE: 20030212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-04-17
1
0000906709
NEKTAR THERAPEUTICS
NKTR
0001218574
GARDINER SANDRA A.
NEKTAR THERAPEUTICS
455 MISSION BAY BLVD S
SAN FRANCISCO
CA
94158
0
1
0
0
Chief Financial Officer
No securities are beneficially owned.
Ex-24 Power of Attorney
Mark A. Wilson, Attorney-in-Fact
2023-04-25
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned's hereby authorizes Mark A.
Wilson, Chief Legal Officer of Nektar Therapeutics, as well as any officer of
Nektar Therapeutics (the "Company") to execute for and on behalf of the
undersigned, in the undersigned's capacity as an executive officer of the
Company, Forms 3, 4 and 5, and any amendments thereto, and cause such Forms(s)
to be filed with the United States Securities and Exchange Commission pursuant
to Section 16(a) of the Securities Act of 1934, relating to the undersigned's
beneficial ownership of securities in the Company. The undersigned hereby grants
to each such attorney-in-fact full power and authority to do and perform any and
every act and thing whatsoever requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of, and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 24th day of April, 2023.
/s/ Sandra A. Gardiner
_________________________________
Signature
Sandra A. Gardiner
_________________________________
Print Name